BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15695078)

  • 1. One-year morbidity after sentinel node biopsy and breast surgery.
    Rönkä R; von Smitten K; Tasmuth T; Leidenius M
    Breast; 2005 Feb; 14(1):28-36. PubMed ID: 15695078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance.
    Leidenius M; Leivonen M; Vironen J; von Smitten K
    J Surg Oncol; 2005 Oct; 92(1):23-31. PubMed ID: 16180231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
    Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
    Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
    Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; De Vries J; Dolsma W; Groothoff JW; Eisma WH; Hoekstra HJ
    Cancer; 2003 Aug; 98(4):690-6. PubMed ID: 12910511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy and quality of life measures in a Chinese population.
    Chen JJ; Huang XY; Liu ZB; Chen TW; Cheng JY; Yang WT; Xu WP; Shao ZM; Shen ZZ; Wu J
    Eur J Surg Oncol; 2009 Sep; 35(9):921-7. PubMed ID: 19233602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of arm lymphoedema following sentinel node biopsy, axillary sampling and axillary dissection in patients with breast cancer.
    Lumachi F; Basso SM; Bonamini M; Marino F; Marzano B; Milan E; Waclaw BU; Chiara GB
    In Vivo; 2009; 23(6):1017-20. PubMed ID: 20023249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step axillary operation increases risk of arm morbidity in breast cancer patients.
    Husen M; Paaschburg B; Flyger HL
    Breast; 2006 Oct; 15(5):620-8. PubMed ID: 16513350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
    Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
    Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients.
    Langer I; Kocher T; Guller U; Torhorst J; Oertli D; Harder F; Zuber M
    Breast Cancer Res Treat; 2005 Mar; 90(1):85-91. PubMed ID: 15770531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer.
    Barranger E; Dubernard G; Fleurence J; Antoine M; Darai E; Uzan S
    J Surg Oncol; 2005 Oct; 92(1):17-22. PubMed ID: 16180226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.
    Purushotham AD; Upponi S; Klevesath MB; Bobrow L; Millar K; Myles JP; Duffy SW
    J Clin Oncol; 2005 Jul; 23(19):4312-21. PubMed ID: 15994144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
    Rietman JS; Geertzen JH; Hoekstra HJ; Baas P; Dolsma WV; de Vries J; Groothoff JW; Eisma WH; Dijkstra PU
    Eur J Surg Oncol; 2006 Mar; 32(2):148-52. PubMed ID: 16387467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
    Fleissig A; Fallowfield LJ; Langridge CI; Johnson L; Newcombe RG; Dixon JM; Kissin M; Mansel RE
    Breast Cancer Res Treat; 2006 Feb; 95(3):279-93. PubMed ID: 16163445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
    Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
    Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.